These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 21660299

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Long-acting beta(2)-agonist in addition to tiotropium versus either tiotropium or long-acting beta(2)-agonist alone for chronic obstructive pulmonary disease.
    Karner C, Cates CJ.
    Cochrane Database Syst Rev; 2012 Apr 18; 4(4):CD008989. PubMed ID: 22513969
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effects of tiotropium or combined therapy with salmeterol on hyperinflation in COPD.
    Eguchi Y, Tateishi Y, Umeda N, Yoshikawa T, Kamoi H, Kanazawa H, Kudoh S, Hirata K, Fujimoto S.
    Osaka City Med J; 2007 Jun 18; 53(1):25-34. PubMed ID: 17867631
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Additive efficacy of short-acting bronchodilators on dynamic hyperinflation and exercise tolerance in stable COPD patients treated with long-acting bronchodilators.
    Kitaguchi Y, Fujimoto K, Komatsu Y, Hanaoka M, Honda T, Kubo K.
    Respir Med; 2013 Mar 18; 107(3):394-400. PubMed ID: 23245993
    [Abstract] [Full Text] [Related]

  • 8. Outcomes in COPD patients receiving tiotropium or salmeterol plus treatment with inhaled corticosteroids.
    Hodder R, Kesten S, Menjoge S, Viel K.
    Int J Chron Obstruct Pulmon Dis; 2007 Mar 18; 2(2):157-67. PubMed ID: 18044688
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of tiotropium and indacaterol monotherapy and their combination on dynamic lung hyperinflation in COPD: a random open-label crossover study.
    Fujimoto K, Yamazaki H, Ura M, Kitaguchi Y.
    Int J Chron Obstruct Pulmon Dis; 2017 Mar 18; 12():3195-3201. PubMed ID: 29138547
    [Abstract] [Full Text] [Related]

  • 10. Changes in lung function and health status in patients with COPD treated with tiotropium or salmeterol plus fluticasone.
    Kurashima K, Hara K, Yoneda K, Kanauchi T, Kagiyama N, Tokunaga D, Takayanagi N, Ubukata M, Sugita Y.
    Respirology; 2009 Mar 18; 14(2):239-44. PubMed ID: 19210650
    [Abstract] [Full Text] [Related]

  • 11. Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial.
    Aaron SD, Vandemheen KL, Fergusson D, Maltais F, Bourbeau J, Goldstein R, Balter M, O'Donnell D, McIvor A, Sharma S, Bishop G, Anthony J, Cowie R, Field S, Hirsch A, Hernandez P, Rivington R, Road J, Hoffstein V, Hodder R, Marciniuk D, McCormack D, Fox G, Cox G, Prins HB, Ford G, Bleskie D, Doucette S, Mayers I, Chapman K, Zamel N, FitzGerald M, Canadian Thoracic Society/Canadian Respiratory Clinical Research Consortium.
    Ann Intern Med; 2007 Apr 17; 146(8):545-55. PubMed ID: 17310045
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of once-daily indacaterol 75 μg relative to alternative bronchodilators in COPD: a study level and a patient level network meta-analysis.
    Cope S, Zhang J, Williams J, Jansen JP.
    BMC Pulm Med; 2012 Jun 25; 12():29. PubMed ID: 22732017
    [Abstract] [Full Text] [Related]

  • 13. Tiotropium versus salmeterol in COPD.
    Lloret-Linares C, Bergmann JF.
    N Engl J Med; 2011 Jun 30; 364(26):2552-3; author reply 2553-4. PubMed ID: 21714656
    [No Abstract] [Full Text] [Related]

  • 14. Tiotropium versus salmeterol in COPD.
    Schembri S.
    N Engl J Med; 2011 Jun 30; 364(26):2553; author reply 2553-4. PubMed ID: 21714655
    [No Abstract] [Full Text] [Related]

  • 15. Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.
    Keam SJ, Keating GM.
    Treat Respir Med; 2004 Jun 30; 3(4):247-68. PubMed ID: 15350163
    [Abstract] [Full Text] [Related]

  • 16. Bronchodilation improves endurance but not muscular efficiency in chronic obstructive pulmonary disease.
    van der Vaart H, Postma DS, Grevink R, Roemer W, ten Hacken N.
    Int J Chron Obstruct Pulmon Dis; 2011 Jun 30; 6():229-35. PubMed ID: 21660300
    [Abstract] [Full Text] [Related]

  • 17. Tiotropium versus salmeterol in COPD.
    Oba Y.
    N Engl J Med; 2011 Jun 30; 364(26):2553; author reply 2553-4. PubMed ID: 21714654
    [No Abstract] [Full Text] [Related]

  • 18. Long-acting beta 2-adrenoceptor agonists or tiotropium bromide for patients with COPD: is combination therapy justified?
    Tennant RC, Erin EM, Barnes PJ, Hansel TT.
    Curr Opin Pharmacol; 2003 Jun 30; 3(3):270-6. PubMed ID: 12810191
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of tiotropium and olodaterol combination therapy on dynamic lung hyperinflation evaluated by hyperventilation in COPD: an open-label, comparative before and after treatment study.
    Kawachi S, Fujimoto K.
    Int J Chron Obstruct Pulmon Dis; 2019 Jun 30; 14():1167-1176. PubMed ID: 31213796
    [Abstract] [Full Text] [Related]

  • 20. Tiotropium and exercise training in COPD patients: effects on dyspnea and exercise tolerance.
    Ambrosino N, Foglio K, Balzano G, Paggiaro PL, Lessi P, Kesten S, Tiotropium Multicentric Italian Study Group.
    Int J Chron Obstruct Pulmon Dis; 2008 Jun 30; 3(4):771-80. PubMed ID: 19281092
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.